Description

Introducing Itracard-200: Advanced Antifungal Therapy

Potent Antifungal Action: Each capsule of Itracard-200 delivers 200mg of Itraconazole, which inhibits ergosterol synthesis in fungal cell membranes, effectively treating a wide range of fungal infections.

Broad Spectrum Effectiveness: Targets dermatophytes, yeasts, and molds, ensuring comprehensive treatment for various fungal pathogens.

Optimized Absorption: Formulated for optimal bioavailability, facilitating rapid onset of action and swift resolution of fungal infections.

Convenient Once-Daily Dosing: Simplifies treatment with once-daily capsules, promoting patient compliance and consistent therapeutic levels.

Clinical Confidence: Backed by clinical research, Itracard-200 is recognized for its proven efficacy and safety in managing fungal infections.

Manufacturing Excellence: Manufactured under stringent quality standards by Anevay Pharmaceuticals, ensuring pharmaceutical integrity and reliable treatment outcomes.